JPS5029732A - - Google Patents

Info

Publication number
JPS5029732A
JPS5029732A JP49050660A JP5066074A JPS5029732A JP S5029732 A JPS5029732 A JP S5029732A JP 49050660 A JP49050660 A JP 49050660A JP 5066074 A JP5066074 A JP 5066074A JP S5029732 A JPS5029732 A JP S5029732A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49050660A
Other versions
JPS5714649B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5029732A publication Critical patent/JPS5029732A/ja
Publication of JPS5714649B2 publication Critical patent/JPS5714649B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP5066074A 1973-05-05 1974-05-07 Expired JPS5714649B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2150273A GB1422176A (en) 1973-05-05 1973-05-05 Pharmaceutical tablets
GB5685873 1973-12-07

Publications (2)

Publication Number Publication Date
JPS5029732A true JPS5029732A (ja) 1975-03-25
JPS5714649B2 JPS5714649B2 (ja) 1982-03-25

Family

ID=26255363

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5066074A Expired JPS5714649B2 (ja) 1973-05-05 1974-05-07

Country Status (10)

Country Link
JP (1) JPS5714649B2 (ja)
CA (1) CA1018890A (ja)
DE (1) DE2421273A1 (ja)
DK (1) DK145712C (ja)
FR (1) FR2227856B1 (ja)
GB (1) GB1422176A (ja)
IE (1) IE39216B1 (ja)
IL (1) IL44646A (ja)
NL (1) NL7406023A (ja)
SE (1) SE402405B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950977A1 (de) * 1978-12-22 1980-07-10 Donald E Panoz Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
DE3239592C2 (de) * 1982-10-26 1986-10-30 Institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga Antibakterielles Arzneimittel
DE3668116D1 (de) * 1985-10-19 1990-02-15 Beecham Group Plc Zusammensetzung zur behandlung von infektionen.
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
EP1728511A1 (en) * 2005-05-31 2006-12-06 Faust Pharmaceuticals New use of phenethicillin and salts thereof.
DK2531178T3 (da) * 2010-02-03 2014-09-01 Merck Patent Gmbh Direkte komprimerbart magnesiumhydroxidcarbonat
JP5835849B2 (ja) * 2011-03-17 2015-12-24 協和化学工業株式会社 圧縮成形物およびその製造方法

Also Published As

Publication number Publication date
IL44646A (en) 1977-04-29
AU6853574A (en) 1975-11-06
NL7406023A (ja) 1974-11-07
JPS5714649B2 (ja) 1982-03-25
DK145712C (da) 1983-07-25
IE39216L (en) 1974-11-05
IE39216B1 (en) 1978-08-30
CA1018890A (en) 1977-10-11
SE402405B (sv) 1978-07-03
FR2227856B1 (ja) 1978-02-03
DK145712B (da) 1983-02-07
GB1422176A (en) 1976-01-21
DE2421273A1 (de) 1974-11-14
FR2227856A1 (ja) 1974-11-29
IL44646A0 (en) 1974-06-30

Similar Documents

Publication Publication Date Title
AR201758A1 (ja)
AU476761B2 (ja)
AR201235Q (ja)
AR201231Q (ja)
FR2227856B1 (ja)
AU476714B2 (ja)
AR201229Q (ja)
AR199451A1 (ja)
AU477823B2 (ja)
AR195311A1 (ja)
AR193950A1 (ja)
AR200256A1 (ja)
AU476873B1 (ja)
AR200885A1 (ja)
AU477824B2 (ja)
AR197627A1 (ja)
AR196382A1 (ja)
AR210729A1 (ja)
AR201432A1 (ja)
AR195948A1 (ja)
AR196212Q (ja)
AR196123Q (ja)
BG18570A1 (ja)
AU479458A (ja)
CH562924A5 (ja)